TriLink BioTechnologies Company
TriLink manufactures custom oligonucleotides, modified nucleotides, long RNA and mRNA for the diagnostic, therapeutic and OEM markets.
Headquarters:
San Diego, California, United States
Funding Status:
M&A
Estimated Revenue:
$10M to $50M
Technology:
Cancer
Founded Date:
1996
Industry:
Gene Therapy